Neurelis Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Neurelis

Access the complete profile.

Neurelis Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	3430 Carmel Mountain Rd Ste 300 San Diego, CA 92121

Note: Revenues for privately held companies are statistical evaluations.


Neurelis's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Neurelis's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Neurelis is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Neurelis Annual Revenue and Growth Rate

Neurelis	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Neurelis's revenues are gauged from an analysis of company filings.

Neurelis's Income Statement (based on Industry Averages)

Neurelis P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Neurelis is developing and marketing. Neurelis doesn't have any recent trademark applications, indicating Neurelis is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
N NEURELIS OUR PASSION IS PROGRESS providing medical information accessible via a global computer network	03/06/2020
MYNEURELIS PERSONALIZED SUPPORT FOR PATIENTS & CARE PARTNERS Educational services and support related to pharmaceutical products, namely, providing trainings in the field of pharmaceutical products and for the treatment of nervous system disorders	01/30/2020
OUR PASSION IS PROGRESS Educational services and support related to pharmaceutical products, namely, providing trainings in the field of pharmaceutical products and for the treatment of nervous system disorders	01/30/2020

See all trademarks and details in the Full Report.

Market Share of Neurelis's Largest Competitors

A competitive analysis shows these companies are in the same general field as Neurelis, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Neurelis. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MARAVAI INTERMEDIATE HOLDINGS	San Diego, CA	100
CUE HEALTH	San Diego, CA	95
AJINOMOTO ALTHEA	San Diego, CA	73
NEURELIS	San Diego, CA	20
ZENTALIS PHARMACEUTICALS	San Diego, CA	18
PLEXIUM	San Diego, CA	14

Future Competition: Neurelis's Fastest Growing Competitors

These companies are in the same general field as Neurelis and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)